Outcome measures among patients with retinoblastoma in middle-income countries
| Outcome measures (% patients) | ||||
| Country | Total number of patients | Estimated survival | Metastatic disease at diagnosis | Incidence of treatment refusal |
| Upper middle income countries | ||||
| Argentina | 472 | 93 | 3 | 2 |
| Belarus* | 120 | 85 | NA | 5 |
| Brazil | 1317 | 78 | 12 | 19 |
| Chile* | NA | 90 | NA | NA |
| Costa Rica* | 79 | 80 | 16 | NA |
| Hungary | 95 | 83 | 1 | NA |
| Malaysia | 151 | 54 | 20 | NA |
| Mexico | 1545 | 75 | 7 | NA |
| Oman | 32 | 82 | 7 | 3 |
| Poland | 114 | 85 | NA | NA |
| Saudi Arabia | 820 | 67 | 24 | 16 |
| Serbia | 227 | 78 | NA | 11 |
| South Africa | 154 | 55 | 15 | NA |
| South Korea | 70 | 90 | NA | NA |
| Turkey | 1677 | 86 | 6 | 2 |
| Uruguay* | NA | 90 | NA | NA |
| Venezuela | 126 | 78 | 3 | NA |
| Lower middle income countries | ||||
| Central America | 324 | 60 | 16 | 29 |
| Cuba* | 157 | 92 | NA | 1 |
| China | 965 | 63 | 15 | 20 |
| Colombia* | 13 | 92 | NA | NA |
| Ecuador* | 75 | 66 | NA | NA |
| Egypt | 89 | 60 | 31 | 25 |
| Iran | 715 | 77 | 6 | 10 |
| Jordan | 66 | 90 | 3 | 9 |
| Morocco | 85 | 77 | 17 | NA |
| Peru* | 443 | 60 | NA | 37 |
| Philippines* † | 392 | NA | NA | NA |
| Roumania* † | 31 | NA | NA | NA |
| Russian Federation | 144 | 87 | 20 | 10 |
| Taiwan | 162 | 69 | 11 | 13 |
| Thailand | 90 | 78 | 13 | 17 |
| Tunis | 70 | 87 | 11 | NA |